Brompheniramine Maleate (Brompheniramine Maleate)
Overview of Brompheniramine Maleate
Brompheniramine (Maleate) is antihistaminic agent. Brompheniramine (Maleate) is probably effective for temporary relief of hay fever (allergic rhinitis affecting the mucous membranes of the eyes and respiratory tract caused by pollen of certain plants) and upper respiratory allergic symptoms, such as itchy, watery eyes, sneezing.
Indication of Brompheniramine Maleate
Brompheniramine Maleate is primarily indicated in conditions like Allergic conjunctivitis, Allergic rhinitis, Dermatitis, NSAID associated ulceration, Urticaria, and can also be given in adjunctive therapy as an alternative drug of choice in Asthma.
Contraindication of Brompheniramine Maleate
Brompheniramine (Maleate) is contraindicated in conditions like Porphyria,General dose.
Side Effects of Brompheniramine Maleate
The severe or irreversible adverse effects of Brompheniramine (Maleate), which give rise to further complications include Hallucinations, Brain damage or epilepsy, Aggression, Sleep disturbances, Grand-mal seizures.,Brompheniramine (Maleate) produces potentially life-threatening effects which include Agranulocytosis. which are responsible for the discontinuation of Brompheniramine (Maleate) therapy.,The signs and symptoms that are produced after the acute overdosage of Brompheniramine (Maleate) include Hypotension, Convulsions, Coma.,The symptomatic adverse reactions produced by Brompheniramine (Maleate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dry mouth, Blurred vision, Sedation.
Precautions of Brompheniramine Maleate
Brompheniramine should be used with caution in bone marrow depression. Patients should observe caution while driving or performing other task requiring alertness because it may cause drowsiness. It should be used with caution in patients with urinary retention, history of bronchial asthma, hyperthyroidism, cardiovascular or liver disease. It should be used with caution in person with acute or chronic respiratory impairment, especially in children. Do not administer subcutaneously, because irritation or lesion may occur.